This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Korea Basic Science Institute. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Park Min Shin: Innovator in Cancer Diagnosis
Introduction
Park Min Shin is a notable inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of cancer diagnosis through his innovative research and development. His work focuses on utilizing glycoproteins and lectins to improve cancer detection methods.
Latest Patents
Park Min Shin holds a patent for a method for diagnosing cancer using lectin. This invention relates to diagnosing cancer by analyzing aberrant glycosylation of glycoproteins, which is closely associated with cancer progression. The patent outlines a process where glycoproteins that are aberrantly glycosylated due to cancer are isolated using lectin. Furthermore, it details the selection and quantification of marker peptides generated from the hydrolysis of these glycoproteins. He has 1 patent in this area.
Career Highlights
Park Min Shin is affiliated with the Korea Basic Science Institute, where he continues to advance his research in cancer diagnostics. His work has the potential to significantly impact early cancer detection and treatment strategies.
Collaborations
Some of his notable coworkers include Yeong Hee Ahn and Jong Shin Yoo, who contribute to his research endeavors.
Conclusion
Park Min Shin's innovative approach to cancer diagnosis exemplifies the importance of research in medical science. His contributions are paving the way for more effective cancer detection methods, ultimately benefiting patients worldwide.